{"database": "lobbying", "table": "lobbying_activities", "rows": [[3232477, "f4c76a4d-4bff-4b2c-87fe-c5d2dea84611", "3T", "WILLIAMS AND JENSEN, PLLC", 41454, "MT PHARMA AMERICA, INC.", 2024, "third_quarter", "MMM", "Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases; matters affecting infusion therapies. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 1, "2024-10-04T11:16:14-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3232477"], "units": {}, "query_ms": 2.5078540202230215, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}